Assessment of ischemic heart disease using magnetic resonance first-pass perfusion imaging

Herz

Volumn 28, Issue 2, 2003, Pages 82-89

  Mühling, Olaf ^a,d   Jerosch Herold, Michael ^b   Näbauer, Michael ^a   Wilke, Norbert ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Endocardial perfusion; Ischemic heart disease; Magnetic resonance; Myocardial perfusion

Indexed keywords

ADENOSINE; CONTRAST MEDIUM; GADOLINIUM; PENTETIC ACID;

ANGIOGENESIS; ARTICLE; CELL VIABILITY; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ENDOCARDIAL RESTING PERFUSION RATIO; EPIMYOCARDIAL RESTING PERFUSION RATIO; EVALUATION; EXERCISE TEST; FIRST PASS EFFECT; HEART FUNCTION; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART TRANSPLANTATION; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL RESOLUTION; PARAMETER; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; RADIATION EXPOSURE; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNDROME X; TREATMENT INDICATION;

CORONARY DISEASE; CORONARY STENOSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL ISCHEMIA; REPRODUCIBILITY OF RESULTS; TISSUE SURVIVAL; VENTRICULOGRAPHY, FIRST-PASS;

EID: 0037355514     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-003-2458-z     Document Type: Article

References (45)

1. Al Saadi N, Nagel E, Gross M, et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 2000;101:1379-83.
2. Al Saadi N, Nagel E, Gross M, et al. Improvement of myocardial perfusion reserve early after coronary intervention: assessment with cardiac magnetic resonance imaging [In Process Citation]. J Am Coll Cardiol 2000;36:1557-64.
3. Blardi P, Laghi PF, Urso R, et al. Pharmacokinetics of exogenous adenosine in man after infusion. Eur J Clin Pharmacol 1993;44: 505-7.
4. Burstein D, Taratuta E, Manning WJ. Factors in myocardial "perfusion" imaging with ultrafast MRI and Gd-DTPA administration. Magn Reson Med 1991;20:299-305.
5. Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 1974;33:87-94.
6. Henry TD, Rocha-Singh K, Isner JM, et al. Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. Am Heart J 2001; 142:872-80.
7. Hollenberg SM, Klein LW, Parrillo JE, et al. Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death. Circulation 2001;104:3091-6.
8. Hosenpud JD, Bennett LE, Keck BM, et al. The Registry of the International Society for Heart and Lung Transplantation: sixteenth official report - 1999. J Heart Lung Transplant 1999;18: 611-26.
9. Jerosch-Herold M, Swingen C, Seethamraju RT. Myocardial blood flow quantification with MRI by model-independent deconvolution. Med Phys 2002;29:886-97.
10. Jerosch-Herold M, Wilke N. MR first pass imaging: quantitative assessment of transmural perfusion and collateral flow. Int J Card Imaging 1997;13:205-18.
11. Jerosch-Herold M, Wilke N, Stillman AE. Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution. Med Phys 1998;25:73-84.
12. Johnson TH, McDonald K, Nakhleh R, et al. Allograft vasculopathy and death in a cardiac transplant patient with angiographically normal coronary arteries. Cathet Cardiovasc Diagn 1991;24: 37-40.
13. Keijer JT, Van Rossum AC, Wilke N, et al. Magnetic resonance imaging of myocardial perfusion in single-vessel coronary artery disease: implications for transmural assessment of myocardial perfusion. J Cardiovasc Magn Reson 2000;2:189-200.
14. Kemp HG Jr. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol 1973;32:375-6.
15. Kemp HG, Kronmal RA, Vlietstra RE, et al. Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study. J Am Coll Cardiol 1986;7:479-83.
16. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
17. Kroll K, Wilke N, Jerosch-Herold M, et al. Modeling regional myocardial flows from residue functions of an intravascular indicator. Am J Physiol 1996;271:H1643-55.
18. Lauerma K, Virtanen KS, Sipila LM, et al. Multislice MRI in assessment of myocardial perfusion in patients with single-vessel proximal left anterior descending coronary artery disease before and after revascularization. Circulation 1997;96:2859-67.
19. Legrand V, Hodgson JM, Bates ER, et al. Abnormal coronary flow reserve and abnormal radionuclide exercise test results in patients with normal coronary angiograms. J Am Coll Cardiol 1985;6:1245-53.
20. Martin ET, Fuisz AR, Pohost GM. Imaging cardiac structure and pump function. Cardiol Clin 1998;16:135-60.
21. McGinn AL, Wilson RF, Olivari MT, et al. Coronary vasodilator reserve after human orthotopic cardiac transplantation. Circulation 1988;78:1200-9.
22. Meeder JG, Blanksma PK, Crijns HJ, et al. Mechanisms of angina pectoris in syndrome X assessed by myocardial perfusion dynamics and heart rate variability. Eur Heart J 1995;16:1571-7.
23. Muehling O, Dickson M, Zenovich A, et al. Quantitative magnetic resonance first-pass perfusion analysis: inter- and intraobserver agreement. J Cardiovasc Magn Reson 2001;3:247-256.
24. Muehling O, Panse P, Zenovich A, et al. Detection of a decreased endo-/epicardial perfusion in the transplanted human heart with cardiac MRI. Circulation 2001;104:3625.abstract.
25. Muehling O, Wang Y, Panse P, et al. Transmyocardial laser revascularization preserves regional myocardial perfusion: an MRI first pass perfusion study. Cardiovasc Res 2002;57:63-70.
26. Muzik O, Duvernoy C, Beanlands RS, et al. Assessment of diagnostic performance of quantitative flow measurements in normal subjects and patients with angiographically documented coronary artery disease by means of nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1998;31:534-40.
27. Nihoyannopoulos P, Kaski JC, Crake T, et al. Absence of myocardial dysfunction during stress in patients with syndrome X. J Am Coll Cardiol 1991;18:1463-70.
28. Panting JR, Gatehouse PD, Yang GZ, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002;346: 1948-53.
29. Pearlman JD, Laham RJ, Simons M. Coronary angiogenesis: detection in vivo with MR imaging sensitive to collateral neocirculation - preliminary study in pigs. Radiology 2000;214:801-7.
30. Rosen SD, Uren NG, Kaski JC, et al. Coronary vasodilator reserve, pain perception, and sex in patients with syndrome X. Circulation 1994;90:50-60.
31. Schwaiger M, Muzik O. Assessment of myocardial perfusion by positron emission tomography. Am J Cardiol 1991;67:35D-43D.
32. Schwitter J, Nanz D, Kneifel S, et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 2001;103:2230-5.
33. Tsekos NV, Zhang Y, Merkle H, et al. Fast anatomical imaging of the heart and assessment of myocardial perfusion with arrhythmia insensitive magnetization preparation. Magn Reson Med 1995;34:530-6.
34. Tweddel AC, Martin W, Hutton I. Thallium scans in syndrome X. Br Heart J 1992;68:48-50.
35. Uren NG, Melin JA, De Bruyne B, et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 1994;330:1782-8.
36. White CW, Wright CB, Doty DB, et al. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? N Engl J Med 1984;310:819-24.
37. Wilke N, Jerosch-Herold M. Assessing myocardial perfusion in coronary artery disease with magnetic resonance first-pass imaging. Cardiol Clin 1998;16:227-46.
38. Wilke N, Jerosch-Herold M, Wang Y, et al. Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 1997;204:373-84.
39. Wilke NM, Jerosch-Herold M, Zenovich A, et al. Magnetic resonance first-pass myocardial perfusion imaging: clinical validation and future applications. J Magn Reson Imaging 1999;10: 676-85.
40. Wilson RF. Assessment of the human coronary circulation using a Doppler catheter. Am J Cardiol 1991;67:44D-56D.
41. Wilson RF, White CW. Measurement of maximal coronary flow reserve: a technique for assessing the physiologic significance of coronary arterial lesions in humans. Herz 1987;12:163-76.
42. Wilson RF, Wyche K, Christensen BV, et al. Effects of adenosine on human coronary arterial circulation. Circulation 1990;82: 1595-606.
43. Yeung AC, Davis SF, Hauptman PJ, et al. Incidence and progression of transplant coronary artery disease over 1 year: results of a multicenter trial with use of intravascular ultrasound. Multicenter Intravascular Ultrasound Transplant Study Group. J Heart Lung Transplant 1995;14:S215-20.
44. Zaacks SM, Ali A, Parrillo JE, et al. How well does radionuclide dipyridamole stress testing detect three-vessel coronary artery disease and ischemia in the region supplied by the most stenotic vessel? Clin Nucl Med 1999;24:35-41.
45. Zierler KL. Theoretical basis of indicator-dilution methods for measuring flow and volume. Circ Res 1962;10:393-407.